»Winner of National Science Fund for Excellent Young Scholars

Wu Baojian

Wu Baojian, Professor and Doctoral supervisor, serves as the Director of the Institute of Molecular Rhythms and Metabolism at Guangzhou University of Chinese Medicine. His primary research areas include chronopharmacology and the circadian rhythms of diseases. He has contributed as the main corresponding or first author to over 140 SCI papers, published in renowned journals such asNature Communications,Hepatology,Advanced Science, andScience Advances. Wu Baojian has been recognized for his scholarly achievements, selected as thewinner ofNational Science Fund forExcellentYoungScholarsand NationalYoungQihuang Scholar, as well as being included in the National 863 Young Scientists and Guangdong Provincial Outstanding Youth Talent Project. His contributions have led to his inclusion in various prestigious rankings, such as the "2020 Global Top 2% Scientists Lifetime Scientific Impact Ranking," "2021 Global Top 100,000 Scientists Ranking" in the fields of pharmacology and pharmacy, and the "2022 Global Scholar Academic Impact Ranking" in pharmaceutical sciences. His accolades include the ISSX Asia-Pacific Young Scholar Award, the Fourth Liu Changxiao Talent Incentive Fund "Excellent Young Scientific and Technological Worker" Award, and the Guangdong Pharmacological Society 2020 Science and Technology Achievement Award (Second Prize). Wu Baojian has also taken on the role of chief editor for academic monographs likeDrug Metabolism and Transport,Biological Clock and Pharmacokinetics, andCircadian Pharmacokinetics. In addition to his research, Wu Baojian contributes to the academic community as an editorial board member for journals such asBiochemical Pharmacology,Drug Metabolism and Disposition,Frontiers in Pharmacology(Associate Editor),Journal of Pharmaceutical Sciences,Expert Opinion on Drug Metabolism & Toxicology,Journal of Pharmacy and Pharmacology,Xenobiotica,Archives of Biochemistry and Biophysics, andCurrent Drug Metabolism(Co-Editor). He also serves as a young editorial board member for theChinese Journal of Pharmacology(in both Chinese and English) andChinese Medicine.